Roberto Bordonaro, MD, chair, medical oncology, Garibaldi Hospital, Catania, Italy, discusses treatment options for patients with colorectal cancer who fail on oxaliplatin- and irinotecan-based chemotherapy.
Roberto Bordonaro, MD
Advertisement
Articles by Roberto Bordonaro, MD
Roberto Bordonaro, MD, discusses first-line treatment options for advanced colorectal cancer (CRC).
Advertisement
Latest Updated Articles
Dr. Bordonaro on First-Line Treatment Options for mCRCPublished: January 24th 2014 | Updated:
- Dr. Bordonaro on the Treatment of Advanced CRC
Published: March 13th 2014 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
3
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
4
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
5